For the project, GE will develop an advanced visualization platform with 2D/3D annotation tools for medical image analysis; a software development kit to develop clinical, therapeutic, and research applications for imaging; and a technology framework for meeting regulatory requirements for medical applications.

The consortium will include the following companies and organizations:

• The Curie Institute
• The Gustave Roussy Institute
• Pixyl
• SME Evolucare
• The Greater Paris Group of Hospitals (APHP)
• The Paris Hospital Saint Joseph Foundation
• Therapanacea

Applications to be developed will include managing liver cancer with AI characterization tools, the diagnosis and prognosis of lung diseases, and personalized treatment for brain cancer. The 13-million-euro initiative is supported by a program called Investments for the Future, which is led by the French Secretary General for Investment and operated by Bpifrance, GE said.